Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD)

Published:2023-10-09 Issue:10 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Iffland Michelle¹,Livingstone Nuala²,Jorgensen Mikaela¹,Hazell Philip³,Gillies Donna¹⁴

Affiliation:

1. Senior Practitioner Branch; NDIS Quality and Safeguards Commission; Penrith Australia

2. Cochrane Evidence Production and Methods Directorate ; Cochrane; London UK

3. Speciality of Psychiatry; University of Sydney School of Medicine; Sydney Australia

4. Sydney Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference634 articles.

1. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial;Akhondzadeh;Journal of Clinical Pharmacy and Therapeutics,2004

2. A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder;Akhondzadeh;Child Psychiatry and Human Development,2008

3. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism;Akhondzadeh;Progress in Neuro-Psychopharmacology and Biological Psychiatry,2010

4. Safety and efficacy of memantine in children with autism: randomized, placebo-controlled study and open-label extension;Aman;Journal of Child and Adolescent Psychopharmacology,2017

5. Study of pharmacokinetics, safety, efficacy, and tolerability of memantine in children with autism clinicaltrials.gov/ct2/show/NCT00872898

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the spectrum: overlap, distinctions, and nuances of ADHD and ASD in children;Frontiers in Psychiatry;2024-09-13

2. Emerging Treatments and Therapies for Autism Spectrum Disorder: A Narrative Review;Cureus;2024-07-02

3. Cannabinoid treatment for the symptoms of autism spectrum disorder;Expert Opinion on Emerging Drugs;2024-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3